Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Baricitinib is effective and safe for treating severe alopecia areata.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

RANK-RANKL signaling is essential for hair growth and skin health.

Prolactin slows down hair growth in mice.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

MSC-EVs and UCB-EVs improve skin wound healing and reduce scarring.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

c-Kit is important for heart regeneration and cancer development.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Gray hair can potentially be reversed, leading to new treatments.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

New treatments for severe alopecia areata show promise but lack standard approval.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.